StonvexLoading…
StonvexStonvexStonvexCore line items from AMRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.02B | $2.79B | $2.39B | $2.21B |
Operating Income | $394.10M | $249.33M | $204.37M | $-94.93M |
Net Income | $72.06M | $-116.89M | $-83.99M | $-270.58M |
EPS (Diluted) | $0.22 | $-0.38 | $-0.48 | $-0.86 |
Total Assets | $3.68B | $3.50B | $3.47B | $3.80B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $282.03M | $110.55M | $91.54M | $25.98M |
Free Cash Flow OCF − CapEx | $269.93M | $243.18M | $302.36M | $18.69M |
Shares Outstanding | 324.81M | 308.98M | 176.14M | 150.94M |